Example: Heart Attack

Search clinical trials for: Irofulven

Total 20 results

    • NCT03643107
      Active, not recruiting
      Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
      Conditions: Metastatic Castration-Resistant Prostate Cancer Patients
    • NCT00003441
      Completed
      Irofulven in Treating Patients With Metastatic Colorectal Cancer
      Conditions: Colorectal Cancer
    • NCT00053365
      Completed
      Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
      Conditions: Primary Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer
    • NCT00374660
      Unknown status
      Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
      Conditions: Liver Cancer
    • NCT00124527
      Completed
      Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer
      Conditions: Thyroid Cancer
    • NCT00003666
      Completed
      Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
      Conditions: Lung Cancer
    • NCT00003796
      Completed
      Irofulven in Treating Patients With Metastatic Breast Cancer
      Conditions: Breast Cancer
    • NCT00003786
      Withdrawn
      Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
      Conditions: Colorectal Cancer
    • NCT00033735
      Completed
      Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
      Conditions: Pancreatic Cancer
    • NCT00003370
      Completed
      Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
      Conditions: Unspecified Childhood Solid Tumor, Protocol Specific
    • NCT00062257
      Completed
      Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
      Conditions: Gastric Cancer
    • NCT00005968
      Completed
      Irofulven in Treating Patients With Stage IV Melanoma
      Conditions: Melanoma (Skin)
    • NCT00005070
      Completed
      Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer
      Conditions: Cervical Cancer
    • NCT00005031
      Completed
      Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
      Conditions: Endometrial Cancer
    • NCT00003997
      Completed
      6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
      Conditions: Leukemia; Myelodysplastic Syndromes
    • NCT00019552
      Completed
      Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
      Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
    • NCT00003390
      Completed
      6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
      Conditions: Kidney Cancer
    • NCT00003760
      Completed
      Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
      Conditions: Pancreatic Cancer
    • NCT00124566
      Completed
      Study of Irofulven in Patients With Hormone-refractory Prostate Cancer
      Conditions: Prostate Cancer
    • NCT00012038
      Completed
      Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors
      Conditions: Brain and Central Nervous System Tumors
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations